Sheng Liu
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 5
- Oncology top 10%
- Cancer Cells and Metastasis 9
- Pancreatic and Hepatic Oncology Research 3
- Molecular Biology top 10%
- Epigenetics and DNA Methylation 7
- Histone Deacetylase Inhibitors Research 4
- Single-cell and spatial transcriptomics 4
- RNA Interference and Gene Delivery 3
- Geriatrics and Gerontology top 10%
-
- Immune cells in cancer 6
- Co-authors
- Jun WanYunlong LiuXiongbin LuKevin Van der JeughtYujing LiXiaoming HeAnna Maria StornioloJiang Qian
- Partner nations
- United StatesChinaCanada
In The Last Decade
Sheng Liu
63 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 114
- Cancer Research 271
- Oncology 343
- Molecular Biology 759
- Geriatrics and Gerontology 43
- Immunology 206
Countries citing papers authored by Sheng Liu
This map shows the geographic impact of Sheng Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheng Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheng Liu more than expected).
Fields of papers citing papers by Sheng Liu
This network shows the impact of papers produced by Sheng Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheng Liu. The network helps show where Sheng Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sheng Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 3 | |
| 3 | 2025 | 2 | |
| 4 | 2024 | 2 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 35 | |
| 7 | 2023 | 5 | |
| 8 | 2021 | 78 | |
| 9 | 2021 | 1 | |
| 10 | 2020 | 28 | |
| 11 | 2020 | 56 | |
| 12 | 2019 | 97 | |
| 13 | 2019 | 28 | |
| 14 | 2019 | 38 | |
| 15 | Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer | 2019 | 1 |
| 16 | 2019 | 122 | |
| 17 | 2018 | 38 | |
| 18 | Neutralizing negative epigenetic regulation by HDAC5 enhances human haematopoietic stem cell homing and engraftment | 2018 | 1 |
| 19 | 2018 | 2 | |
| 20 | Reliability test and failure analysis of high power LED packages | 2011 | 6 |
About Sheng Liu
Sheng Liu is a scholar working on Oncology, Cancer Research and Molecular Biology, having authored 65 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (9 papers), Epigenetics and DNA Methylation (7 papers), Immune cells in cancer (6 papers), Cancer Genomics and Diagnostics (5 papers), Histone Deacetylase Inhibitors Research (4 papers), Single-cell and spatial transcriptomics (4 papers), RNA Interference and Gene Delivery (3 papers) and Pancreatic and Hepatic Oncology Research (3 papers). The work is most often cited by research in Cancer Research (271 citations), Oncology (343 citations) and Molecular Biology (759 citations). Sheng Liu has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Jun Wan, Yunlong Liu, Xiongbin Lu, Kevin Van der Jeught, Yujing Li, Xiaoming He, Anna Maria Storniolo, Jiang Qian, Guoqing Liao and George E. Sandusky.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.